SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-336444
Filing Date
2017-11-08
Accepted
2017-11-08 07:01:26
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d441588d10q.htm 10-Q 686356
2 EX-31.1 d441588dex311.htm EX-31.1 6923
3 EX-31.2 d441588dex312.htm EX-31.2 6943
4 EX-32.1 d441588dex321.htm EX-32.1 4403
  Complete submission text file 0001193125-17-336444.txt   3487045

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sndx-20170930.xml EX-101.INS 537493
6 XBRL TAXONOMY EXTENSION SCHEMA sndx-20170930.xsd EX-101.SCH 45689
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20170930_cal.xml EX-101.CAL 55915
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20170930_def.xml EX-101.DEF 145820
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20170930_lab.xml EX-101.LAB 355361
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20170930_pre.xml EX-101.PRE 247203
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 171185030
SIC: 2834 Pharmaceutical Preparations